WILMINGTON, Del., May 27, 2025 (GLOBE NEWSWIRE) -- In a move aiming to change the construction materials distribution landscape, nexxbuild is thrilled to announce its strategic merger (the "Merger") with Investcorp Europe Acquisition Corp I (IVCBF:US) ("IVCB"). This partnership signifies a step in nexxbuild's mission to unify independent local distributors under a cohesive nationwide platform, enhancing their service capabilities and expanding their market reach. "Today marks the beginning of an exciting fu ...

Core Insights - NewGenIvf Group Limited has launched First Fertility PGS Center Limited to target the Indian medical tourism market for fertility treatments [1][2] - The global fertility tourism market is projected to grow from US$709 million in 2023 to approximately US$13.08 billion by 2034, with a compound annual growth rate of 30.34% [2] - Thailand is becoming a preferred destination for fertility tourism due to its advanced medical infrastructure, cost-effective treatments, and supportive regulatory environment [2][4] Company Initiatives - First Fertility has developed culturally tailored services for Indian patients, including a dedicated hospitality lounge and Hindi-speaking staff [3] - The center offers comprehensive fertility treatments, including family balance through IVF, which is restricted in India but legally available in Thailand [3] - The initiative aims to create a culturally sensitive environment while providing access to advanced reproductive technologies [3] Market Positioning - Thailand's strategic advantages, such as visa-free entry for Indian nationals and a progressive regulatory environment, support the growth of the medical tourism sector [4] - First Fertility addresses the gap in culturally tailored fertility care for Indian patients, who represent a significant segment of the medical tourism market [4] - The CEO of NewGen emphasized the company's commitment to providing world-class fertility care while capitalizing on market opportunities in Southeast Asia [5]

Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore's Sales Organization Focused on Executing Three-Pronged Growth Strategy CHASKA, Minn., May 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has appoi ...

Follow IEC’s vision through its multi-weekly updates on LinkedIn and its website JAKARTA, INDONESIA AND DANVILLE, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE American: INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, issued today a letter to shareholders from the company’s senior management outlining IEC’s strategic vision and dedication to playing a key role in energy development in Indonesia as well as the country’s future in general. You c ...

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX and NYSE American: FURY) ("Fury" or the "Company") announces that it has entered into a subscription agreement with Agnico Eagle Mines Limited ("Agnico Eagle") pursuant to which Agnico Eagle has acquired, on a non-brokered private placement basis, 6,728,000 units in the capital of the Company ("Units") at C$0.64 per Unit for gross proceeds of C$4,305,920 (the "Private Placement"). Each Unit consists of one common share of Fury ("Share(s) ...

– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest – – LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with LUCIA to follow – WATERTOWN, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutic ...

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a clean technology company reprocessing mine waste to produce precious and critical metals whilst promoting environmental and social sustainability, is pleased to announce that it has signed an agreement dated May 22, 2025 with a leading North American mining company to commence the Company’s proprietary NVRO Expedited Deployment Pathway. The client’s tailings have been ...

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the "Company" or "Emerita") is pleased to provide updated results on its metallurgical testing program (the "Program") for its wholly-owned Iberian Belt West Project ("IBW" or the "Project") for base and precious metals. The CLEVR Process™ optimization for La Romanera deposit is a post-flotation stage of metallurgical recovery that is being conducted at DUNDEE Sustainable Technologies' laboratories. A ...

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President and Interim Chief Executive Officer, participated in the BofA Securities 2025 AgTech Virtual Conference this week. During the fireside chat, hosted by BofA research analyst Stephen Byrne, management di ...

NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that the Nasdaq Hearings Panel granted the Company's request to continue its listing on The Nasdaq Stock Market. During a Nasdaq Panel hearing held on May 1, 2025, the Panel reviewed the Company's plan and strategies to regain compliance with Listing Rule 5550(b)(2) (the "MVLS (market v ...